Alterations in ether lipid metabolism in obesity revealed by systems genomics of multi-omics datasets

  • Yvette L. Schooneveldt
  • , Sudip Paul
  • , Kevin Huynh
  • , Habtamu B. Beyene
  • , Nat A. Mellett
  • , Gerald F. Watts
  • , Joseph Hung
  • , Jennie Hui
  • , John Beilby
  • , John Blangero
  • , Eric K. Moses
  • , Jonathan E. Shaw
  • , Dianna J. Magliano
  • , Marcus M. Seldin
  • , Brian G. Drew
  • , Anna C. Calkin
  • , Corey Giles
  • , Peter J. Meikle

Research output: Contribution to journalArticlepeer-review

Abstract

Ratios between two metabolites are sensitive indicators of metabolic changes. Lipidomic profiling studies have revealed that plasma ether lipids, a class of glycero- and glycerophospho-lipids with reported health benefits, are negatively associated with obesity. Here, we utilized lipid ratios as surrogate markers of lipid metabolism to explore the processes underlying the inverse relationship between ether lipid metabolism and obesity. Plasma lipidomics data from two independent human cohorts (n=10,339 and n=4,492) were integrated to assess the associations between 82 lipid ratios and obesity-related markers in males and females. Results were externally validated using mouse transcriptomics data from the Hybrid Mouse Diversity Panel (n=152−227 across 74 strains). Genome-wide association studies using imputed genotypes from a population cohort (n=4,492) were performed to examine the genetic architecture of the ratios. Findings showed that waist circumference (WC), body mass index, and waist–hip ratio were inversely associated with total plasmalogens relative to total phospholipids in both sexes. Ratios comprising product–substrate pairs positioned either side of enzymes involved in plasmalogen synthesis and degradation showed positive and negative associations with WC, respectively. Branched-chain fatty acids negatively correlated with WC, while omega-6 polyunsaturated fatty acids exhibited differing associations depending on their position within the pathway. Mouse transcriptomics corroborated these results. Genomics data showed strong associations between ratios containing choline-plasmalogens and single-nucleotide polymorphisms in the transmembrane protein 229B (TMEM229B) gene region. This work demonstrates the utility of lipid ratios in understanding lipid metabolism. By applying the ratios to multi-omic datasets, we identified alterations in enzymatic activity and genetic variants likely affecting ether lipid synthesis in obesity that could not have been obtained from lipidomics data alone. Additionally, we characterized a potential role for TMEM229B, offering new perspectives on ether lipid metabolism and regulation.

Original languageEnglish
Article numbere3003349
Number of pages26
JournalPLoS Biology
Volume23
Issue number8
DOIs
Publication statusPublished - Aug 2025

Funding

FundersFunder number
NHMRC National Health and Medical Research Council 2027256, 1173952, 2009965, 2016530, 1197190, 2016668, 1101320

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Alterations in ether lipid metabolism in obesity revealed by systems genomics of multi-omics datasets'. Together they form a unique fingerprint.

    Cite this